| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |